Management of Alcohol Withdrawal
Benzodiazepines are the gold standard treatment for alcohol withdrawal syndrome and should be used to prevent seizures and delirium tremens, with long-acting agents (chlordiazepoxide, diazepam) preferred for most patients, but lorazepam specifically indicated for those with liver failure, advanced age, or severe comorbidities. 1, 2
Initial Assessment and Risk Stratification
Evaluate for serious complications requiring inpatient admission 1:
- History of withdrawal seizures or delirium tremens
- Significant current withdrawal symptoms
- High levels of recent drinking
- Serious medical or psychiatric comorbidities
- Previous outpatient treatment failure
Monitor vital signs frequently to detect autonomic hyperactivity (hypertension, tachycardia, fever, sweating), as symptoms typically peak at 3-5 days after cessation 1. Carefully evaluate for comorbidities including dehydration, electrolyte imbalance, renal failure, head trauma, infection, GI bleeding, pancreatitis, and liver failure 1.
CIWA-Ar Scale Limitations
While the CIWA-Ar can guide severity assessment (>8 indicates moderate AWS, ≥15 indicates severe), it is not recommended for diagnosis as high scores occur in other conditions (anxiolytic withdrawal, anxiety disorders, sepsis, hepatic encephalopathy, severe pain) 1, 2. Use symptom-triggered regimens rather than fixed-dose schedules to prevent drug accumulation 2.
Benzodiazepine Selection and Dosing
Standard Patients (No Liver Disease)
Long-acting benzodiazepines provide superior seizure and delirium prevention 1, 2:
High-Risk Patients (Liver Failure, Elderly, Respiratory Compromise)
Lorazepam is specifically recommended for patients with severe AWS, advanced age, recent head trauma, liver failure, respiratory failure, other serious medical comorbidities, or obesity 1:
- Lorazepam: Start 6-12 mg/day divided (1-4 mg every 4-8 hours PO/IV/IM), taper after symptom resolution 1
The 2022 French guidelines note that short-acting benzodiazepines in cirrhotic patients lack validation from controlled trials, and all benzodiazepines are affected by hepatic insufficiency 3. However, the practical recommendation remains lorazepam or oxazepam for hepatic dysfunction 2.
Taper benzodiazepines following resolution of withdrawal symptoms and avoid use beyond 10-14 days due to abuse potential 2.
Thiamine Supplementation (Critical)
All patients with AWS must receive thiamine to prevent Wernicke encephalopathy 1:
- Prevention: 100-300 mg/day for 4-12 weeks (some guidelines extend to 2-3 months) 1
- Treatment of Wernicke encephalopathy: 100-500 mg/day for 12-24 weeks 1
Critical timing: Administer thiamine before IV fluids containing glucose, as glucose administration may precipitate acute thiamine deficiency 1.
Supportive Care
Provide 1:
- Fluids and electrolyte replacement (especially magnesium)
- Vitamins
- Calm, comfortable environment
- Frequent reassessment
Second-Line and Adjunctive Therapies
Carbamazepine
Alternative to benzodiazepines effective for seizure prevention 1:
- 200 mg PO every 6-8 hours 1
Haloperidol
Use cautiously as adjunctive therapy only for agitation or psychotic symptoms (hallucinations) not controlled by benzodiazepines 1:
- 0.5-5 mg PO every 8-12 hours, or 2-5 mg IM 1
Phenobarbital and Propofol
For treatment-resistant withdrawal, phenobarbital or propofol demonstrate efficacy 4. Propofol can serve as an induction agent to decrease withdrawal effects in severe cases 4.
Dexmedetomidine
Does not address underlying GABA pathophysiology but may reduce intubation need; requires further study 4.
Refractory Withdrawal and Delirium Tremens
When benzodiazepines fail to control symptoms despite escalating doses, consider:
- Higher-acuity care setting (ICU)
- Phenobarbital as adjunct
- Propofol for severe cases
- Continuous monitoring for complications 5
Psychiatric Consultation
Psychiatric consultation is recommended (A1 recommendation) for evaluation, acute management, and long-term abstinence planning 1.
Common Pitfalls to Avoid
- Do not use CIWA-Ar for diagnosis—only for monitoring severity in appropriate patients 1
- Never give glucose before thiamine—precipitates Wernicke encephalopathy 1
- Avoid long-acting benzodiazepines in liver failure—use lorazepam instead 1
- Do not continue benzodiazepines beyond acute withdrawal (10-14 days maximum) due to abuse risk 2
- Do not use haloperidol as monotherapy—only as adjunct for specific symptoms 1